The study was made to explore the feasibility of increasing the delivery of gemcitabine-HCL (Gem) an unhealthy membrane permeable and short half-life medication through PEGylated thermosensitive liposomal nanoparticles (TSLnps) delivery system accompanied by minor hyperthermia (mTH) at 42°C. worth of Jewel treated cells was (0.077μM) 1.2 fold higher in comparison to that treated with Gem-TSLnps… Continue reading The study was made to explore the feasibility of increasing the